Riskpilot← Back to searchSign inGet full accessMoleculent AB
ABActiveOrg 5593178907Scheeles Väg 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 202151 employees
Revenue 2025
SEK 0
EBITDA margin
—
+4% vs 2024
Equity ratio
89.2%
Financial strength
Net profit 2025
SEK -103,4M
+3% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -100,5M | +4% |
| Net profit | SEK -103,4M | +3% |
| Total assets | SEK 125,6M | -45% |
| Equity | SEK 112,1M | -48% |
| Employees | 51 | — |
Legal name
Moleculent AB
Org number
5593178907
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18 maj 2021
Share capital
SEK 371 390
Employees
51 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av Ericsson, John Olof Kendall, Sean Prescott Roos, Fredrik Martin Weiss, Patrick Alan Öhman, Per Ove i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva forskning och utveckling av produkter inom life science samt därmed förenlig verksamhet.
Address
Scheeles Väg 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | −0 | −0 | 0 |
| Staff expenses | — | −13 457 | −26 606 | −39 846 | −48 764 |
| EBITDA | −7 325 | −28 440 | −67 718 | −104 400 | −100 534 |
| Depreciation & amort. | −29 | −669 | −2 668 | −4 131 | −5 814 |
| EBIT | −7 354 | −29 108 | −70 387 | −108 531 | −106 347 |
| Net financials | — | 3 | 1 250 | 2 123 | 2 899 |
| Profit before tax | −7 354 | −29 106 | −69 137 | −106 408 | −103 448 |
| Tax | −0 | — | — | — | — |
| Net profit | −7 354 | −29 106 | −69 137 | −106 408 | −103 448 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 26 282 | 106 011 | 44 503 | 228 482 | 125 620 |
| Equity | 24 373 | 101 370 | 33 091 | 215 419 | 112 107 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 1 909 | 4 641 | 11 412 | 13 063 | 13 513 |
| Total debt | 1 909 | 4 641 | 11 412 | 13 063 | 13 513 |
EBITDA margin
-10053352400.0%
This company
15.8%
Market median
-63628812758% vs market
20212025
Equity ratio
89.2%
This company
38.2%
Market median
+134% vs market
20212025
Return on equity
-92.3%
This company
18.4%
Market median
-602% vs market
20212025
Net profit margin
-10344795800.0%
This company
8.1%
Market median
-127713528495% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-05-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JH | Audit | 2021 |
JO Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Former (5) | ||
| Deputy Board Member | 2021 – 2022 | |
| Chairman | 2022 – 2024 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Moleculent AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Henrik Forsberg | Audit | 0 companies |
| John Olof Ericsson | Chief Executive Officer | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Anders Birger Nordström | Chairman | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Geoffrey Paul Smith | Board of Directors | 0 companies |
| Gunnar Magnus Severus Persson | Board of Directors | 0 companies |
| Per Ove Öhman | Board of Directors | 0 companies |
| Patrick Alan Weiss | Chairman | 0 companies |
| Sean Prescott Kendall | Board of Directors | 0 companies |
| Fredrik Martin Roos | Board of Directors | 0 companies |